These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3666080)

  • 1. Irradiation exposure modulates central opioid functions.
    Dougherty PM; Dafny N
    Exp Neurol; 1987 Nov; 98(2):301-16. PubMed ID: 3666080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of an immune system to brain communication axis that affects central opioid functions: muramyl peptides attenuate opiate withdrawal.
    Dougherty PM; Drath DB; Dafny N
    Eur J Pharmacol; 1987 Sep; 141(2):253-60. PubMed ID: 2824218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response products alter CNS activity: interferon modulates central opioid functions.
    Dafny N; Lee JR; Dougherty PM
    J Neurosci Res; 1988; 19(1):130-9. PubMed ID: 2449543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats.
    Dougherty PM; Pellis NR; Dafny N
    Neuroscience; 1990; 36(2):285-9. PubMed ID: 2215925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune system and opiate withdrawal.
    Dafny N; Dougherty PM; Pellis NR
    Int J Immunopharmacol; 1989; 11(4):371-5. PubMed ID: 2674032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimmune intercommunication, central opioids, and the immune response to bacterial endotoxin.
    Dougherty PM; Dafny N
    J Neurosci Res; 1988; 19(1):140-8. PubMed ID: 3343705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of haloperidol on morphine-induced antinociception morphine tolerance and withdrawal in hyperprolactinaemic rats.
    Drago F; Kovács GL; Szabo G; Scapagnini U; Telegdy G
    Neuropharmacology; 1985 Nov; 24(11):1027-31. PubMed ID: 4080101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine.
    Buccafusco JJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):209-15. PubMed ID: 6682228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.
    Marshall DC; Buccafusco JJ
    Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level microwave irradiation attenuates naloxone-induced withdrawal syndrome in morphine-dependent rats.
    Lai H; Horita A; Chou CK; Guy AW
    Pharmacol Biochem Behav; 1986 Jan; 24(1):151-3. PubMed ID: 3945661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone alters the local metabolic rate for glucose in discrete brain regions associated with opiate withdrawal.
    Kraus MA; Piper JM; Kornetsky C
    Brain Res; 1996 Jun; 724(1):33-40. PubMed ID: 8816253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.